Inogen (NASDAQ: INGN) has announced the appointment of Andy Reding to the newly created role of chief operating officer (COO), effective Monday, July 6, 2026.
Mr. Reding will be responsible for driving revenue and operational performance, aligning cross-functional priorities, and helping ensure Inogen’s strategy is translated into efficient and measurable outcomes.
In a statement, Kevin Smith, CEO of Inogen, commented, “As we continue to diversify Inogen’s business through new product launches and geographic expansion, we are streamlining our leadership structure to enhance execution and accelerate delivery of our strategic priorities. Andy’s deep experience building high-performing teams and scaling complex medical technology businesses will be invaluable as we continue to drive top-line growth, advance profitability and expand the innovation pipeline.”
